National Institute of Biomedical Imaging and Bioengineering Notice of Proposed Reorganization, 40278-40279 [2023-13098]

Download as PDF 40278 Federal Register / Vol. 88, No. 118 / Wednesday, June 21, 2023 / Notices Comments on the ICR must be received on or before July 21, 2023. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Sherrette Funn, Sherrette.Funn@hhs.gov or (202) 264–0041. When submitting comments or requesting information, please include the document identifier 0937—New–30D and project title for reference. DATES: Interested persons are invited to send comments regarding this burden estimate or any SUPPLEMENTARY INFORMATION: Services (HHS), requests a new clearance for the collection of performance measures specifically for new FY2023Teen Pregnancy Prevention (TPP) Program grantees. In FY2023, OPA expects to award 5-year TPP cooperative agreements to up to 96 organizations across three Notice of Funding Opportunities (NOFOs). Collection of performance measures is a requirement of all TPP awards and is included in the NOFOs. The semiannual data collection will allow OPA to comply with federal accountability and performance requirements, inform stakeholders of grantee progress in meeting TPP program goals, provide OPA with metrics for monitoring FY2023 TPP grantees, and facilitate individual grantees’ continuous quality improvement efforts within their projects. OPA requests clearance for three years. other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: FY2023 Teen Pregnancy Prevention Performance Measures. Type of Collection: New. OMB No. 0937–NEW–OASH—Office of Population Affairs (OPA). Abstract: The Office of Population Affairs (OPA), in the Office of the Assistant Secretary for Health (OASH), U.S. Department of Health and Human ESTIMATED ANNUALIZED BURDEN TABLE Number of respondents Type of respondent Average burden per response (in hours) Total burden hours TPP Tier 1 & Tier 2 Rigorous Impact grantees ............................................... Tier 1 Grantees (Supportive Services Form) .................................................. Tier 2 Innovation Network Grantees ................................................................ 86 70 10 2 2 2 8 15/60 1 1,376 35 20 Total .......................................................................................................... ........................ 2 ........................ 1,431 Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. [FR Doc. 2023–13173 Filed 6–20–23; 8:45 am] BILLING CODE 4150–34–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting lotter on DSK11XQN23PROD with NOTICES1 Number responses per respondent Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The cooperative agreement applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly VerDate Sep<11>2014 18:36 Jun 20, 2023 Jkt 259001 unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Translational Centers for Microphysiological Systems Review. Date: July 17–18, 2023. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892. Contact Person: Victor Henriquez, Ph.D., Scientific Review Officer, Office of Scientific Director, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1080, Bethesda, MD 20892–4878, 301–451– 2405, henriquv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 Dated: June 15, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–13184 Filed 6–20–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering Notice of Proposed Reorganization AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will host a public online forum to enable public discussion of the Institute’s proposal to establish the Section on Mechanics and Tissue Remodeling Integrating Computational & Experimental Systems (MATRICES). The proposed reorganization will more accurately reflect the current structure by which the Intramural Research SUMMARY: E:\FR\FM\21JNN1.SGM 21JNN1 Federal Register / Vol. 88, No. 118 / Wednesday, June 21, 2023 / Notices Program is functioning and improve the coordination of the scientific activities within the Institute. The online forum will allow members of the public to review the reorganization proposal and submit comments. DATES: The public online forum will become available on June 26, 2023, and will remain open for five calendar days, through June 30, 2023. Any interested person may file written comments by sending an email to NIBIBorgchange@ nih.gov. The statement should include the individual’s name, and when applicable, professional affiliation. ADDRESSES: The public forum will be held online, at https://www.nibib. nih.gov/about-nibib/proposed-orgchanges for the period of time listed above. FOR FURTHER INFORMATION CONTACT: Frank Flannery, Management Analyst, National Institute of Biomedical Imaging and Bioengineering, NIH, (301) 451– 0713, NIBIBorgchange@nih.gov. SUPPLEMENTARY INFORMATION: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), NIBIB will have a public hearing to discuss the proposed reorganization plans. This announcement and the public forum serve as that notice. Ann G. Gawalt, Acting Executive Officer, National Institute of Biomedical Imaging and Biomedical Engineering, National Institutes of Health. [FR Doc. 2023–13098 Filed 6–20–23; 8:45 am] BILLING CODE 4140–01–P Dated: June 15, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2023–13183 Filed 6–20–23; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P lotter on DSK11XQN23PROD with NOTICES1 National Cancer Institute; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Cancer Centers Study Section (A). VerDate Sep<11>2014 18:36 Jun 20, 2023 Jkt 259001 Date: August 2, 2023. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel and Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, Maryland 20852. Contact Person: Shamala K. Srinivas, Ph.D., Associate Director, Office of Referral, Review, and Program Coordination, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W530, Rockville, Maryland 20850, 240–276–6442, ss537t@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Liver Cancer Projects with the Cirrhosis Network. Date: August 4, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850 (Virtual Meeting). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Rockville, Maryland 20850, 240–276–6371, decluej@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 40279 applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Social and Community Influences Across the Life Course. Date: July 12–13, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David E. Pollio, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1006F, Bethesda, MD 20892, (301) 594–4002, polliode@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Respiratory Sciences. Date: July 13, 2023. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Stefania Senger, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–867–5309, stefania.senger@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Epidemiology and Population Sciences. Date: July 17–18, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: James J. Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301–806– 8065, lijames@csr.nih.gov. Name of Committee: Infectious Diseases and Immunology A Integrated Review Group; HIV Molecular Virology, Cell Biology, and Drug Development Study Section. Date: July 17–18, 2023. Time: 10:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435– 1166, roebuckk@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 23–003: Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences. E:\FR\FM\21JNN1.SGM 21JNN1

Agencies

[Federal Register Volume 88, Number 118 (Wednesday, June 21, 2023)]
[Notices]
[Pages 40278-40279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13098]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering 
Notice of Proposed Reorganization

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institute of Biomedical Imaging and 
Bioengineering (NIBIB) will host a public online forum to enable public 
discussion of the Institute's proposal to establish the Section on 
Mechanics and Tissue Remodeling Integrating Computational & 
Experimental Systems (MATRICES). The proposed reorganization will more 
accurately reflect the current structure by which the Intramural 
Research

[[Page 40279]]

Program is functioning and improve the coordination of the scientific 
activities within the Institute. The online forum will allow members of 
the public to review the reorganization proposal and submit comments.

DATES: The public online forum will become available on June 26, 2023, 
and will remain open for five calendar days, through June 30, 2023. Any 
interested person may file written comments by sending an email to 
[email protected]. The statement should include the individual's 
name, and when applicable, professional affiliation.

ADDRESSES: The public forum will be held online, at https://www.nibib.nih.gov/about-nibib/proposed-org-changes for the period of 
time listed above.

FOR FURTHER INFORMATION CONTACT: Frank Flannery, Management Analyst, 
National Institute of Biomedical Imaging and Bioengineering, NIH, (301) 
451-0713, [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to the NIH Reform Act of 2006 (42 
U.S.C. 281(d)(4)), NIBIB will have a public hearing to discuss the 
proposed reorganization plans. This announcement and the public forum 
serve as that notice.

Ann G. Gawalt,
Acting Executive Officer, National Institute of Biomedical Imaging and 
Biomedical Engineering, National Institutes of Health.
[FR Doc. 2023-13098 Filed 6-20-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.